NASH company Genfit gains dual listing via NASDAQ offering

Liver disease company Genfit gained $1.85 to $22.17 on Wednesday after the company raised a combined $135.1 million via a NASDAQ offering and concurrent private placement.

In the NASDAQ offering, Genfit S.A. (Euronext:GNFT; NASDAQ:GNFT) raised $125 million through the sale of 6.2 million ADSs at $20.32; each ADS represents one ordinary share. The offering price valued the biotech at $768.8 million. Genfit also raised €9 million ($10.1 million) in an ex-U.S. private placement, selling 500,000 shares at €18...